CFB may also represent a therapeutic target in RA, as CFB deficient mice (CFB-/-) are highly resistant to CIA and CAIA and have a decreased CII-specific IgG antibody response in CIA (Hietala et al., 2002; Banda et al., 2006). This evidence concerns the gene CFB and rheumatoid arthritis.